The difficulty in doing Cytoreductive Surgery (CRS) is balancing the advantages and disadvantages. This study's objective was to document postoperative morbidity and mortality in the short term in relation to surgical outcome in patients having primary Debulking Surgery (PDS) or Interval Debulking Surgery (IDS) in the Netherlands. Retrospective analysis was performed using data from the Dutch Gynecological Oncology Audit (DGOA). Postoperative problems were common as a result. The prognosis of CRS was correlated with the median time to adjuvant chemotherapy and the degree of sequelae. Case mix was adjusted while an analysis of Clavien-Dindo complications by region was conducted. Patients undergoing interval debulking as well as primary debulking surgery were included in the statistical analysis, which was done in Studio. In primary debulking surgery as compared to interval debulking, complications with re-invention were much higher.
